Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Joseph A. Sparano, MD, on the Prognostic Role of Clinical Risk Stratification in ER-Positive, HER2-Negative Breast Cancer

Posted: Monday, July 8, 2019

Joseph A. Sparano, MD, of the Montefiore Medical Center and Albert Einstein Cancer Center, explores how clinical risk stratification can be used in the clinic to improve outcomes in the treatment of early breast cancer, based on the TAILORx trial results.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.